Cure My Disease

Don't miss your cure!

 Log in / Sign up

Magnetic map may improve cancer staging

NCT ID NCT05899985

Ongoing Diagnosis Sponsor: Ferronova Pty Ltd Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study tests a new magnetic tracer, FerroTrace, to find sentinel lymph nodes in people with stomach or esophageal cancer. About 60 participants will receive the tracer before standard treatment, and doctors will compare its accuracy to current methods. The goal is to see if this approach can better detect cancer spread and improve staging.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
FerroTrace (magnetic tracer) and FerroMag detection system
What this could lead to
If successful, this could provide a more accurate way to detect cancer spread in lymph nodes, potentially guiding better treatment decisions.
What could go wrong
This is an early feasibility study with only 60 participants, so results may not apply broadly. The magnetic tracer may not reliably identify all affected nodes.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ESOPHAGEAL CANCER are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

esophageal cancer Esophageal Neoplasms gastric cancer gastric neoplasm gastroesophageal junction adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ESOPHAGEAL CANCER GASTRIC CANCER

Contacts and locations

Locations

  • Austin Hospital

    Heidelberg, Victoria, 3084, Australia

  • Flinders Medical Centre

    Bedford Park, South Australia, 5042, Australia

  • Peter MacCallum Cancer Centre

    Melbourne, Victoria, 3000, Australia

  • Royal Adelaide Hospital

    Adelaide, South Australia, 5000, Australia

More trials for these conditions

Other studies related to the condition(s) this trial covers.